Clinical trials: Anal HSIL
AIN3, AIN2
ANAL PRECANCEROUS LESIONS IN HIGH-RISK PATIENTS.
HIV-positive patients, women with a history of genital neoplasia and patients under pharmacologically immunosuppression (e.g. transplanted recipients, Crohn´s disease and Lupus) are a high-risk population for anal…
- Conditions
- AIN3, AIN2, HSIL, High Grade Squamous Intraepithelial Lesions
- Trial name
- PACCO (NCT05060640)
- Testing
- Detection of anal HSIL in a routine colonoscopy.
- Where
- Portugal
- Volunteers
- 100 people
- Sponsor
- University Fernando Pessoa